(OPTX) Syntec Optics Holdings - Overview
Stock: Polymer Optics, Optical Assemblies, Electro-Optics, Molded Optics, Thin Films
| Risk 5d forecast | |
|---|---|
| Volatility | 143% |
| Relative Tail Risk | -17.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.75 |
| Alpha | 324.65 |
| Character TTM | |
|---|---|
| Beta | 1.596 |
| Beta Downside | 1.680 |
| Drawdowns 3y | |
|---|---|
| Max DD | 92.96% |
| CAGR/Max DD | -0.05 |
Description: OPTX Syntec Optics Holdings January 08, 2026
Syntec Optics Holdings, Inc. (NASDAQ: OPTX) designs, manufactures, and assembles integrated optics and photonics components for defense, medical, and consumer markets, offering polymer-based optics, molded polymer and glass components, opto-mechanical parts, nano-machining, thin-film coatings, and related design and assembly services. The firm was founded in 1981 and operates from Rochester, New York, classifying under the Electronic Components sub-industry in the U.S. market.
Key quantitative signals (as of the most recent FY 2024 filing) include a revenue run-rate of roughly $45 million, a gross margin hovering near 38 % and R&D intensity around 12 % of sales-both in line with peers in the high-precision photonics niche. The sector is being propelled by two macro drivers: sustained U.S. defense budget growth (the DoD’s FY 2025 budget projects a 4 % increase in optics-related procurement) and the expanding demand for minimally invasive medical imaging, which the global photonics market is expected to grow at a CAGR of ~9 % through 2030.
For a deeper, data-driven dive into OPTX’s valuation metrics and comparable peers, you may find ValueRay’s analytics platform a useful next step.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -2.37m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.07 > 0.02 and ΔFCF/TA -12.32 > 1.0 |
| NWC/Revenue: 9.27% < 20% (prev 12.80%; Δ -3.53% < -1%) |
| CFO/TA -0.04 > 3% & CFO -1.03m > Net Income -2.37m |
| Net Debt (10.8m) to EBITDA (412.5k): 26.16 < 3 |
| Current Ratio: 1.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (36.9m) vs 12m ago 15.44% < -2% |
| Gross Margin: 19.84% > 18% (prev 0.27%; Δ 1957 % > 0.5%) |
| Asset Turnover: 106.3% > 50% (prev 104.1%; Δ 2.13% > 0%) |
| Interest Coverage Ratio: -3.15 > 6 (EBITDA TTM 412.5k / Interest Expense TTM 747.6k) |
Altman Z'' 1.56
| A: 0.11 (Total Current Assets 14.6m - Total Current Liabilities 12.0m) / Total Assets 24.6m |
| B: 0.29 (Retained Earnings 7.20m / Total Assets 24.6m) |
| C: -0.09 (EBIT TTM -2.36m / Avg Total Assets 26.4m) |
| D: 0.49 (Book Value of Equity 7.21m / Total Liabilities 14.8m) |
| Altman-Z'' Score: 1.56 = BB |
Beneish M -3.38
| DSRI: 0.90 (Receivables 5.82m/6.80m, Revenue 28.1m/29.4m) |
| GMI: 1.36 (GM 19.84% / 26.90%) |
| AQI: 0.15 (AQ_t 0.01 / AQ_t-1 0.07) |
| SGI: 0.95 (Revenue 28.1m / 29.4m) |
| TATA: -0.05 (NI -2.37m - CFO -1.03m) / TA 24.6m) |
| Beneish M-Score: -3.38 (Cap -4..+1) = AA |
What is the price of OPTX shares?
Over the past week, the price has changed by +49.57%, over one month by +165.85%, over three months by +291.03% and over the past year by +351.81%.
Is OPTX a buy, sell or hold?
What are the forecasts/targets for the OPTX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 10.5 | 20.2% |
OPTX Fundamental Data Overview February 04, 2026
P/B = 22.055
Revenue TTM = 28.1m USD
EBIT TTM = -2.36m USD
EBITDA TTM = 412.5k USD
Long Term Debt = 1.29m USD (from longTermDebt, last quarter)
Short Term Debt = 8.57m USD (from shortTermDebt, last quarter)
Debt = 11.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.8m USD (from netDebt column, last quarter)
Enterprise Value = 56.9m USD (46.2m + Debt 11.4m - CCE 577.9k)
Interest Coverage Ratio = -3.15 (Ebit TTM -2.36m / Interest Expense TTM 747.6k)
EV/FCF = -33.52x (Enterprise Value 56.9m / FCF TTM -1.70m)
FCF Yield = -2.98% (FCF TTM -1.70m / Enterprise Value 56.9m)
FCF Margin = -6.05% (FCF TTM -1.70m / Revenue TTM 28.1m)
Net Margin = -8.44% (Net Income TTM -2.37m / Revenue TTM 28.1m)
Gross Margin = 19.84% ((Revenue TTM 28.1m - Cost of Revenue TTM 22.5m) / Revenue TTM)
Gross Margin QoQ = 12.29% (prev 23.31%)
Tobins Q-Ratio = 2.32 (Enterprise Value 56.9m / Total Assets 24.6m)
Interest Expense / Debt = 1.89% (Interest Expense 214.4k / Debt 11.4m)
Taxrate = 21.0% (US default 21%)
NOPAT = -1.86m (EBIT -2.36m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.22 (Total Current Assets 14.6m / Total Current Liabilities 12.0m)
Debt / Equity = 1.16 (Debt 11.4m / totalStockholderEquity, last quarter 9.81m)
Debt / EBITDA = 26.16 (Net Debt 10.8m / EBITDA 412.5k)
Debt / FCF = -6.35 (negative FCF - burning cash) (Net Debt 10.8m / FCF TTM -1.70m)
Total Stockholder Equity = 11.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -8.97% (Net Income -2.37m / Total Assets 24.6m)
RoE = -20.64% (Net Income TTM -2.37m / Total Stockholder Equity 11.5m)
RoCE = -18.46% (EBIT -2.36m / Capital Employed (Equity 11.5m + L.T.Debt 1.29m))
RoIC = -8.97% (negative operating profit) (NOPAT -1.86m / Invested Capital 20.8m)
WACC = 9.76% (E(46.2m)/V(57.5m) * Re(11.80%) + D(11.4m)/V(57.5m) * Rd(1.89%) * (1-Tc(0.21)))
Discount Rate = 11.80% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 7.44%
Fair Price DCF = unknown (Cash Flow -1.70m)
EPS Correlation: -10.09 | EPS CAGR: 0.0% | SUE: -0.47 | # QB: 0
Revenue Correlation: 16.69 | Revenue CAGR: 0.01% | SUE: N/A | # QB: 0